| Kelly E King, MD | |
|
3600 Joseph Siewick Dr, Fairfax, VA 22033 | |
| (703) 391-3600 | |
| Not Available |
| Full Name | Kelly E King |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 3600 Joseph Siewick Dr, Fairfax, Virginia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1861408932 | NPI | - | NPPES |
| 010113261 | Medicaid | VA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207PE0004X | Emergency Medicine - Emergency Medical Services | 0101054870 (Virginia) | Secondary |
| 207P00000X | Emergency Medicine | 0101054870 (Virginia) | Primary |
| Entity Name | Emergency Medicine Associates Pa Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134117393 PECOS PAC ID: 8022914522 Enrollment ID: O20031208000283 |
News Archive
GlaxoSmithKline Plc, one of the world's largest pharmaceutical companies, has agreed to pay $750 million to settle a U.S. government false-claims lawsuit over the sale of defective drugs. The lawsuit first filed in 2004 by Cheryl D. Eckard, a former global quality assurance manager for the London-based company came to a settlement finally. Eckard, 51, said, "This is not something I wanted to do, but because of patient safety it was necessary." Being the one to bring this to notice she would receive $96 million from the settlement money. She had warned the company earlier but was fired because of her efforts.
Posttraumatic stress disorder (PTSD) is a form of learning that begins at the moment of the exposure to extremely stressful situations and that grows in impact as trauma-related memories are rehearsed and strengthened repeatedly.
Sebacia, Inc., a company dedicated to delivering breakthrough topical treatments to advance dermatology, has announced the presentation of positive clinical results from two independent studies conducted in Europeinvestigating the use of Sebacia gold microparticles to treat acne.
The U.S. Food and Drug Administration today approved the first genetic test that can help some colorectal cancer (CRC) patients and their doctors determine if the drug Erbitux (cetuximab) would be an effective treatment based on the absence of a gene mutation. The therascreen KRAS RGQ PCR Kit can provide information about the KRAS gene mutation in patients whose CRC has spread to other parts of their body (metastasized).
› Verified 8 days ago
| Entity Name | Mep Health Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164483558 PECOS PAC ID: 5193610319 Enrollment ID: O20171212002233 |
News Archive
GlaxoSmithKline Plc, one of the world's largest pharmaceutical companies, has agreed to pay $750 million to settle a U.S. government false-claims lawsuit over the sale of defective drugs. The lawsuit first filed in 2004 by Cheryl D. Eckard, a former global quality assurance manager for the London-based company came to a settlement finally. Eckard, 51, said, "This is not something I wanted to do, but because of patient safety it was necessary." Being the one to bring this to notice she would receive $96 million from the settlement money. She had warned the company earlier but was fired because of her efforts.
Posttraumatic stress disorder (PTSD) is a form of learning that begins at the moment of the exposure to extremely stressful situations and that grows in impact as trauma-related memories are rehearsed and strengthened repeatedly.
Sebacia, Inc., a company dedicated to delivering breakthrough topical treatments to advance dermatology, has announced the presentation of positive clinical results from two independent studies conducted in Europeinvestigating the use of Sebacia gold microparticles to treat acne.
The U.S. Food and Drug Administration today approved the first genetic test that can help some colorectal cancer (CRC) patients and their doctors determine if the drug Erbitux (cetuximab) would be an effective treatment based on the absence of a gene mutation. The therascreen KRAS RGQ PCR Kit can provide information about the KRAS gene mutation in patients whose CRC has spread to other parts of their body (metastasized).
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kelly E King, MD Po Box 494, Nassau, DE 19969-0494 Ph: (302) 569-0352 | Kelly E King, MD 3600 Joseph Siewick Dr, Fairfax, VA 22033 Ph: (703) 391-3600 |
News Archive
GlaxoSmithKline Plc, one of the world's largest pharmaceutical companies, has agreed to pay $750 million to settle a U.S. government false-claims lawsuit over the sale of defective drugs. The lawsuit first filed in 2004 by Cheryl D. Eckard, a former global quality assurance manager for the London-based company came to a settlement finally. Eckard, 51, said, "This is not something I wanted to do, but because of patient safety it was necessary." Being the one to bring this to notice she would receive $96 million from the settlement money. She had warned the company earlier but was fired because of her efforts.
Posttraumatic stress disorder (PTSD) is a form of learning that begins at the moment of the exposure to extremely stressful situations and that grows in impact as trauma-related memories are rehearsed and strengthened repeatedly.
Sebacia, Inc., a company dedicated to delivering breakthrough topical treatments to advance dermatology, has announced the presentation of positive clinical results from two independent studies conducted in Europeinvestigating the use of Sebacia gold microparticles to treat acne.
The U.S. Food and Drug Administration today approved the first genetic test that can help some colorectal cancer (CRC) patients and their doctors determine if the drug Erbitux (cetuximab) would be an effective treatment based on the absence of a gene mutation. The therascreen KRAS RGQ PCR Kit can provide information about the KRAS gene mutation in patients whose CRC has spread to other parts of their body (metastasized).
› Verified 8 days ago
Dr. Mark E Franke, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 3650 Joseph Siewick Dr Ste 101, Fairfax, VA 22033 Phone: 703-391-2020 Fax: 703-391-1211 | |
Dr. John Ryan Jones, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 3600 Joseph Siewick Dr, Fairfax, VA 22033 Phone: 703-391-3996 | |
Calvin Nguyen, EMT Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 12099 Government Center Pkwy, Fairfax, VA 22035 Phone: 571-242-2931 | |
Michael J Born, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 10306 Eaton Pl, Suite 180, Fairfax, VA 22030 Phone: 703-667-3467 Fax: 703-667-3495 | |
Mrs. Kara S Cochran, PA Emergency Medicine Medicare: Medicare Enrolled Practice Location: 3600 Joseph Siewick Dr, Inova Fair Oaks Hospital, Fairfax, VA 22033 Phone: 703-391-3842 | |
Dr. Peggy Lee Carlson, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 3293 Tilton Valley Dr, Fairfax, VA 22033 Phone: 703-264-0387 | |
Raymond Howard Kessler, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 3600 Joseph Siewick Dr, Fairfax, VA 22033 Phone: 504-702-2287 Fax: 504-702-2500 |